Edward Moore
Interventional Cardiology · Evansville, INNPI 1578527263
Payments from drug & device makers
Across 400 payments — averaging $14.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$954
- AstraZeneca$829
- Novartis$768
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$648
- Amgen$371
- Boehringer Ingelheim$297
- plus $2K from 15 others
What the payments were for
- Food & beverage$5,51498%
- Education$982%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 82 | $954 |
| AstraZeneca | 43 | $829 |
| Novartis | 92 | $768 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 46 | $648 |
| Amgen | 26 | $371 |
| Boehringer Ingelheim | 16 | $297 |
| E.r. Squibb & Sons, L.L.C. | 13 | $287 |
| Pfizer | 20 | $283 |
| Merck | 18 | $275 |
| Abiomed | 7 | $217 |
| Abbott | 9 | $178 |
| Astellas Pharma US Inc | 4 | $112 |
| Boston Scientific | 7 | $92 |
| Lantheus Medical Imaging, Inc. | 4 | $65 |
| Sanofi-aventis U.S. LLC | 2 | $50 |
| Medtronic(3 entities) | 3 | $44 |
| Amarin Pharma, Inc. | 3 | $39 |
| Terumo Medical Corporation | 1 | $38 |
| Actelion Pharmaceuticals US, Inc. | 2 | $34 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Cvrx, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAMZYOS$128
How this compares
$5,612 in reported general payments places this provider in the 40th percentile of 170 interventional cardiology providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 23 | $28,410 |
| EliquisApixaban | 18 | $27,254 |
| Repatha SureclickEvolocumab | 23 | $23,993 |
| Atorvastatin Calcium | 62 | $458 |
| Metoprolol Succinate | 30 | $386 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 15 | $241 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 11 | $226 |
| Carvedilol | 25 | $204 |
| Amlodipine Besylate | 11 | $101 |
| Furosemide | 17 | $95 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $768 | $28,41023 claims |
| PfizerEliquis | $283 | $27,25418 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 170 interventional cardiology providers in Indiana.
Other interventional cardiology in Evansville
- Jarrod FrizzellEvansville$559K
- Anthony VoelkelEvansville$19K
- Adeel SiddiquiEvansville$16K
- James HermillerIndianapolis$2.8M
- Jithendra ChoudaryRichmond$1.6M
- Jeffrey BreallIndianapolis$955K
- Samer AbbasEast Chicago$625K
- Brian BigelowIndianapolis$444K
- Saeed ShaikhIndianapolis$366K
- Dean FerreraEast Chicago$298K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.